3ZXE
Crystal structure of Human Galectin-7 in complex with a galactose- benzylphosphate inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-04-19 |
Detector | ADSC QUANTUM 315 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 35.287, 53.459, 138.646 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 69.340 - 1.670 |
R-factor | 0.20595 |
Rwork | 0.205 |
R-free | 0.23633 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1bkz |
RMSD bond length | 0.006 |
RMSD bond angle | 1.085 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.730 |
High resolution limit [Å] | 1.670 | 1.670 |
Rmerge | 0.070 | 0.130 |
Number of reflections | 31402 | |
<I/σ(I)> | 20.4 | 9.6 |
Completeness [%] | 92.9 | 84.4 |
Redundancy | 4.3 | 4.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | 0.1M BISTRISPROPANE, 20% PEG3350, pH 8.5 |